Hypothermic Oxygenated Perfusion (HOPE) for transplantation of Living Donor Liver grafts prone to small for size syndrome - HOPE

Mohamed Rela0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年11月13日

试验速览

暂无简介。

•Donor criteria:
•1.Any living liver donor used for transplantation at Dr. Rela institute within the study period
•2.Any type of donation surgery (open, robotic,..)
•3.Any liver lobe (right, left)
•4.GRWR <0.7 (study arm II: cold storage with 2hrs HOPE) and =0.7 (Study arm I: standard cold storage)
•Recipient Criteria:
•1.Adult recipient (=18years of age) of living related liver transplantation at Dr. Rela Institute
•2.Primary liver transplantation
•3.Donor-recipient ABO compatible or incompatible
•4.Lab MELD of =25points
•5.Recipient with any chronic liver disease with or without cirrhosis with or without liver tumour (HCC, or other)
•6.Consented recipient

•1.Recipient listed due to acute or subacute liver failure
•2.Recipient listed for retransplantation
•3.Recipients with known grade III or IV portal vein thrombosis
•4.Recipients with combined transplantation (e.g., liver + kidney, liver + any other organ)
•Recipients with lab MELD >25points
•5.Recipients with sepsis (ICU requirement) at the time of transplantation
•6.Recipients with ventilation at time of transplantation

发起方

Mohamed Rela